Successful treatment of refractory Behçet's disease with the TNF-alpha blocker infliximab.

Iran J Immunol

Division of Immunology, Allergy and Infectious Diseases (DIAID), Department of Dermatology, Medical University of Vienna, Allgemeines Krankenhaus, Währinger Gürtel 18-20, A-1090 Vienna, Austria.

Published: March 2009

Download full-text PDF

Source

Publication Analysis

Top Keywords

successful treatment
4
treatment refractory
4
refractory behçet's
4
behçet's disease
4
disease tnf-alpha
4
tnf-alpha blocker
4
blocker infliximab
4
successful
1
refractory
1
behçet's
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!